Document:

Exhibit 10.3

 

 

CONFIDENTIAL
INFORMATION AND

INVENTION ASSIGNMENT AGREEMENT

 

As
a condition of my becoming employed as a consultant by Relmada Therapeutics, Inc., a Nevada corporation, or any of its current
or future subsidiaries, affiliates, successors or assigns (collectively, the “Company”), and in consideration
of my consulting relationship with the Company and my receipt of the compensation now and hereafter paid to me by the Company,
I agree to the following:

 

1. Consulting
Relationship. I understand and acknowledge that this Agreement does not alter, amend or expand upon any rights I may have
to continue in the employ of, or the duration of my consulting relationship with, the Company under any existing agreements between
the Company and me or under applicable law. Any consulting relationship between the Company and me, whether commenced prior to
or upon the date of this Agreement, shall be referred to herein as the “Relationship.”

 

2. Duties.
I will perform for the Company such duties as may be designated by the Company from time to time. During the Relationship,
I will devote my best efforts to the interests of the Company and will not engage in other employment or in any activities detrimental
to the best interests of the Company without the prior written consent of the Company.

 

3. Intentionally
left blank.

 

4. Confidential
Information.

 

(a) Company
Information. I agree at all times during the term of my Relationship with the Company and thereafter for 24 months, to
hold in strictest confidence, and not to use, except for the benefit of the Company to the extent necessary to perform my obligations
to the Company under the Relationship, or to disclose to any person, firm, corporation or other entity without written authorization
of the Board of Directors of the Company, any Confidential Information of the Company which I obtain or create. I further agree
not to make copies of such Confidential Information except as authorized by the Company. I understand that “Confidential
Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not
limited to, research, product plans, products, services, suppliers, customer lists and customers (including, but not limited to,
customers of the Company on whom I called or with whom I became acquainted during the Relationship), prices and costs, markets,
software, developments, inventions, laboratory notebooks, processes, formulas, technology, designs, drawings, engineering, hardware
configuration information, marketing, licenses, finances, budgets or other business information disclosed to me by the Company
either directly or indirectly in writing, orally or by drawings or observation of parts or equipment or created by me during the
period of the Relationship, whether or not during working hours. I understand that “Confidential Information”
includes, but is not limited to, information pertaining to any aspects of the Company’s business which is either information
not known by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the
Company, or is otherwise proprietary information of the Company or its customers or suppliers, whether of a technical nature or
otherwise. I further understand that Confidential Information does not include any information which has become publicly known
and made generally available through no wrongful act of mine, was known to me at the time it was disclosed, is lawfully and in
good faith made available to me by a third party who did not derive it, directly or indirectly from the Company, or is information
that is independently discovered or developed by me without violating my obligations under this agreement and which can be demonstrated
by competent evidence.

 

     

     

    

 

 

(b) Prior
Obligations. I represent that my performance of all terms of this Agreement as an consultant of the Company has not breached
and will not breach any agreement to keep in confidence information acquired by me prior or subsequent to the commencement of
my Relationship with the Company, and I will not disclose to the Company or use any inventions, confidential or non-public proprietary
information or material belonging to any previous client, employer or any other party. I will not induce the Company to use any
inventions, confidential or non-public proprietary information or material belonging to any previous client, employer or any other
party. I acknowledge and agree that I have in good faith listed on Exhibit B all agreements (e.g., non-competition agreements,
non-solicitation of customers agreements, non-solicitation of employees agreements, confidentiality agreements, inventions agreements,
etc.) with a current or former employer, or any other person or entity, that may reasonably restrict my ability to recruit or
engage customers or service providers on behalf of the Company, or otherwise relate to or restrict my ability to perform my duties
as a consultant of the Company or any obligation I may have to the Company.

 

(c) Third
Party Information. I recognize that the Company has received and in the future will receive confidential or proprietary
information from third parties subject to a duty on the Company’s part to maintain the confidentiality of such information
and to use it only for certain limited purposes. I agree to hold all such confidential or proprietary information in the strictest
confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work
for the Company consistent with the Company’s agreement with such third party.

 

5. Inventions.

 

(a) Inventions
Retained and Licensed. I have in good faith and to best of my knowledge attached hereto, as Exhibit A, a list describing
with particularity all inventions, original works of authorship, developments, improvements, and trade secrets which were made
by me prior to the commencement of the Relationship (collectively referred to as “Prior Inventions”), which
belong solely to me or belong to me jointly with another, which as of the execution of this agreement may reasonably relate in
any way to any of the Company’s proposed businesses, products or research and development, and which are not assigned to
the Company hereunder; or, if no such list is attached, I represent that there are no such Prior Inventions. If, in the course
of my Relationship with the Company, I incorporate into a Company product, process or machine a Prior Invention owned by me or
in which I have an interest, the Company is hereby granted and shall have a non-exclusive, royalty-free, irrevocable, perpetual,
worldwide license (with the right to sublicense) to make, have made, copy, modify, make derivative works of, use, sell and otherwise
distribute such Prior Invention as part of or in connection with such product, process or machine.

 

    2

     

    

 

 

(b) Assignment
of Inventions. I agree that I will promptly make full written disclosure to Company, will hold in trust for the sole right
and benefit of the Company, and hereby assign to Company, or its designee, all my right, title and interest throughout the world
in and to any and all inventions related to the Company’s technology or development programs as currently operated or contemplated,
original works of authorship, developments, concepts, know-how, improvements or trade secrets, whether or not patentable or registrable
under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived
or developed or reduced to practice, during the period of time in which I am employed by the Company (collectively referred to
as “Inventions”), except as provided in Exhibit A. I further acknowledge that all inventions, original works
of authorship, developments, concepts, know-how, improvements or trade secrets which are made by me (solely or jointly with others)
within the scope of and directly related to Company’s technology or development programs as currently operated or contemplated
and during the period of my Relationship with the Company are “works made for hire” (to the greatest extent
permitted by applicable law) and are compensated by my salary (if I am an employee), unless regulated otherwise by the mandatory
law of the State of New York.

 

(c) Maintenance
of Records. I agree to keep and maintain adequate and current written records of all Inventions made by me (solely or
jointly with others) during the term of my Relationship with the Company. The records may be in the form of notes, sketches, drawings,
flow charts, electronic data or recordings, laboratory notebooks, and any other format. The records will be available to and remain
the sole property of the Company at all times. I agree not to remove such records from the Company’s place of business except
as expressly permitted by Company policy which may, from time to time, be revised at the sole election of the Company for the
purpose of furthering the Company’s business. I agree to return all such records (including any copies thereof) to Company
at the time of termination of my Relationship with the Company as provided for in Section 6.

 

(d) Patent
and Copyright Rights. I agree to assist Company, or its designee, at its expense, in every proper way to secure Company,
or its designee’s, rights in the Inventions and any copyrights, patents, trademarks, mask work rights, moral rights, or
other intellectual property rights relating thereto in any and all countries, including the disclosure to Company, or its designee
of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments,
recordations, and all other instruments which Company or its designee shall deem necessary in order to apply for, obtain, maintain
and transfer such rights and in order to assign and convey to Company or its designee and any successors, assigns and nominees
the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or
other intellectual property rights relating thereto. I further agree that my obligation to execute or cause to be executed, when
it is in my power to do so, any such instrument or papers shall continue after the termination of this Agreement until the expiration
of the last such intellectual property right to expire in any country of the world. If the Company or its designee is unable because
of my mental or physical incapacity or unavailability or for any other reason to secure my signature to apply for or to pursue
any application for any United States or foreign patents, copyright, mask works, or other registrations covering Inventions or
original works of authorship assigned to Company or its designee as above, then I hereby irrevocably designate and appoint Company
and its duly authorized officers and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute
and file any such applications and to do all other lawfully permitted acts to further the application for, prosecution, issuance,
maintenance or transfer of letters patent, copyright or other registrations thereon with the same legal force and effect as if
originally executed by me. I hereby waive and irrevocably quitclaim to Company or its designee any and all claims, which I now
or hereafter have for infringement of any and all proprietary rights assigned to Company or such designee.

 

    3

     

    

 

 

6. Company
Property; Returning Company Documents. I acknowledge and agree that I have no expectation of privacy with respect to the
Company’s telecommunications, networking or information processing systems (including, without limitation, stored company
files, e-mail messages and voice messages) and that my activity and any files or messages on or using any of those systems may
be monitored at any time without notice. I further agree that any property situated on the Company’s premises and owned
by the Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company
personnel at any time with or without notice. I agree that, at the time of termination of my Relationship with the Company, I
will deliver to the Company (and will not keep in my possession, recreate or deliver to anyone else) any and all devices, records,
data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, laboratory notebooks,
materials, flow charts, equipment, other documents or property, or reproductions of any of the aforementioned items, developed
by me pursuant to the Relationship or otherwise belonging to the Company, its successors or assigns. In the event of the termination
of the Relationship, I agree to sign and deliver the “Termination Certification” attached hereto as Exhibit C,
however, my failure to sign and deliver the Termination Certificate shall in no way diminish my continuing obligations under this
Agreement.

 

7. Notification
to Other Parties. 

 

(a)Consultant.
In the event that I leave the employ of the Company as a consultant, I hereby consent to notification by the Company to my new
employer about my rights and obligations under this Agreement.

 

(b)Consultants.
I hereby grant consent to notification by the Company to any other parties besides the Company with whom I maintain a consulting
or employment relationship, including parties with whom such relationship commences after the effective date of this Agreement,
about my rights and obligations under this Agreement.

 

    4

     

    

 

 

8. Solicitation
of Employees, Consultants and Other Parties. I agree that during the term of my Relationship with the Company, and for
a period of Twenty Four (24) months immediately following the termination of my Relationship with the Company for any reason,
whether with or without cause, I shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s
employees or consultants to terminate their relationship with the Company, or attempt to solicit, induce, recruit, encourage or
take away employees or consultants of the Company, either for myself or for any other person or entity. Further, during my Relationship
with the Company and at any time following termination of my Relationship with the Company for any reason, with or without cause,
I shall not use any Confidential Information of the Company to attempt to negatively influence any of the Company’s clients
or customers from purchasing Company products or services or to solicit or influence or attempt to influence any client, customer
or other person either directly or indirectly, to direct his or its purchase of products and/or services to any person, firm,
corporation, institution or other entity in competition with the business of the Company.

 

9. Representations
and Covenants.

 

(a) Facilitation
of Agreement. I agree to execute promptly any proper oath or verify any proper document required to carry out the terms
of this Agreement upon the Company’s written request to do so.

 

(b) Conflicts.
I knowingly represent that my performance of all the terms of this Agreement does not and will not breach any agreement I
have entered into, or will enter into with any third party, including without limitation any agreement to keep in confidence proprietary
information acquired by me in confidence or in trust prior to commencement of my Relationship with the Company. I agree not to
enter into any written or oral agreement that conflicts with the provisions of this Agreement.

 

(c) Voluntary
Execution. I certify and acknowledge that I have carefully read all of the provisions of this Agreement and that I understand
and will fully and faithfully comply with such provisions.

 

10. General
Provisions.

 

(a) Governing
Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the
State of New York, without giving effect to the principles of conflict of laws.

 

(b) Entire
Agreement. This Agreement sets forth the entire agreement and understanding between the Company and me relating to the
subject matter herein and merges all prior discussions between us. No modification or amendment to this Agreement, nor any waiver
of any rights under this Agreement, will be effective unless in writing signed by both parties. Any subsequent change or changes
in my duties, obligations, rights or compensation will not affect the validity or scope of this Agreement.

 

    5

     

    

 

 

(c) Severability.
If one or more of the provisions in this Agreement are deemed void by law, then the remaining provisions will continue in
full force and effect.

 

(d) Successors
and Assigns. This Agreement will be binding upon my heirs, executors, administrators and other legal representatives,
and my successors and assigns, including, any successor entity, and will be for the benefit of the Company, its successors, and
its assigns.

 

(e) Survival.
The provisions of this Agreement shall survive the termination of the Relationship and the assignment of this Agreement by
the Company to any successor in interest or other assignee.

 

(f) Remedies.
I acknowledge and agree that violation of this Agreement by me may cause the Company irreparable harm, and therefore agree that
the Company will be entitled to seek relief in court, including but not limited to temporary restraining orders, preliminary injunctions
and permanent injunctions without the necessity of posting a bond or other security and in addition to and without prejudice to
any other right and remedies that the Company may have for a breach of this Agreement.

 

(g) ADVICE
OF COUNSEL. I ACKNOWLEDGE THAT, IN EXECUTING THIS AGREEMENT, I HAVE HAD THE OPPORTUNITY TO SEEK THE ADVICE OF INDEPENDENT
LEGAL COUNSEL, AND I HAVE READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL NOT BE CONSTRUED
AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF.

 

[Signature
Page Follows]

 

    6

     

    

 

 

The
parties have executed this Confidentiality and Inventions Assignment Agreement on the respective dates set forth below:

 

	COMPANY:	 	CONSULTANT:
	 	 	 	 	 
	RELMADA
    THERAPEUTICS, INC.	 	CHARLES
    S. ENCE
	 	 	 	 	 
	By:  	 	 	Signature: 	 
	 	 	 	 	 
	Name:	Sergio
Traversa	 	Date:	July
29, 2019
	 		 	 	 
	Title:	CEO	 	 	 
	 	 	 	 	 
	Date:	July
    29, 2019	 	 	 

 

    7

     

    

 

 

EXHIBIT
A

 

LIST
OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

EXCLUDED
UNDER SECTION 3

 

☒ No
inventions or improvements

 

☐  Additional
Sheets Attached

 

Signature
of Consultant: ________________

 

Print
Name of Consultant: Charles S. Ence

 

Date:
July 29, 2019

 

    8

     

    

 

 

EXHIBIT
B

 

LIST
OF PRIOR AGREEMENTS

 

	Name of Agreement	 	Parties to Agreement	 	Restrictions(s)
	None	 	 	 	 
	 	 	 	 	 

 

 

 

 

 

 

 

 

 

Consultant’s
Signature: _______________

 

Date:
July 29, 2019

 

    9

     

    

 

 

EXHIBIT
C

 

TERMINATION
CERTIFICATION

 

This
is to certify that I do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals,
lists, correspondence, specifications, drawings, blueprints, sketches, laboratory notebooks, flow charts, materials, equipment,
other documents or property, or copies or reproductions of any aforementioned items belonging to Relmada Therapeutics, Inc., its
subsidiaries, affiliates, successors or assigns (together the “Company”).

 

I
further certify that I have complied with all the terms of the Company’s Confidential Information and Invention Assignment
Agreement signed by me, including the reporting of any inventions and original works of authorship (as defined therein), conceived
or made by me (solely or jointly with others) covered by that agreement.

 

I
further agree that, in compliance with the Confidential Information and Invention Assignment Agreement, I will preserve as confidential
all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs,
formulas, developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists,
business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees,
clients, consultants or licensees.

 

I
further agree that for twenty four (24) months from the date of this Certificate, I shall not either directly or indirectly solicit,
induce, recruit or encourage any of the Company’s employees or consultants to terminate their relationship with the Company,
or attempt to solicit, induce, recruit, encourage or take away, hire, or otherwise engage the services of employees or consultants
of the Company, either for myself or for any other person or entity. Further, I shall not at any time use any Confidential Information
of the Company to negatively influence any of the Company’s clients or customers from purchasing Company products or services
or to solicit or influence or attempt to influence any client, customer or other person either directly or indirectly, to direct
his or its purchase of products and/or services to any person, firm, corporation, institution or other entity in competition with
the business of the Company.

 

Date:                                                          

 

	 	 
		(Consultant’s
Signature)
	 	 
	 	 
	 	(Type/Print
Consultant’s Name)

 

 

 

10Ex 10.1 Severance Letter Agreement

		

			Exhibit 10.1

		

		

			

		

		

			 

		

		

			 

		

		
			﻿
		

		
			﻿
		

		
			Effective July 17, 2019
		

		
			﻿
		

		
			Mr. Timothy M. Storer
		

		
			8350 N Central Expy #1600
		

		
			Dallas, TX 75206
		

		
			﻿
		

		
			﻿
		

		
			Dear Tim:
		

		
			﻿
		

		
			This letter agreement, entered into as of the above Effective Date, summarizes the terms of your departure from A. H. Belo Corporation (the “Company”) and amends your Employment Agreement as set forth herein.  References in this letter agreement to “Employment Agreement” shall mean the Amended and Restated Employment Agreement dated as of December 10, 2018 by and among you, A. H. Belo Corporation and DMV Digital Holdings Company.
		

		
			﻿
		

			
	
			
				 I.
			

			
	
			
			Employment Term.  The Company agrees to pay you and you accept continued employment with the Company through the period ending on December 31, 2019 (the “Employment Period”).  

		
			﻿
		

			
	
			
				 II.
			

			
	
			
			No Coverage Under Company Severance Plans.  The agreements and payments as outlined herein are in lieu of any payments under the A. H. Belo Severance Plan.  You will not continue to be covered under the A. H. Belo Corporation Change in Control Severance Plan as of the Effective Date.

		
			﻿
		

			
	
			
				 III.
			

			
	
			
			Title and Nature of Duties.   As of the Effective Date, you will retain the title of President,  Belo + Company.  Your duties will be those set forth herein.  During the Employment Period, you agree to complete all Q2 2019 corporate governance related items and provide transition assistance for matters related to Belo + Company including, but not limited to: client relationships, sales and marketing efforts, preparing marketing materials, assistance in retention of key talent, operational matters, and fulfillment of contractual commitments to Belo + Company customers. You will have access to Belo + Company offices during your transition at the Company’s discretion; however, you will not be required to be in the office on a regular basis in order to perform these duties and responsibilities.  

		
			You will continue to report to the Company’s Chief Executive Officer and you will provide the other members of the A. H. Belo Management Committee assistance as reasonably requested to facilitate a successful transition, to include the transition matters described above.
		

		

		

		 

		

			P.O.  Box 224866    Dallas, Texas 75222-1866   Tel. 214.977.8222    Fax. 214.977.8285

		

		

			www.ahbelo.com      Deliveries:  1954 Commerce Street     Dallas, Texas  75201

		

		

			 

		

 

		

			 

		

		You shall notify the Company promptly if you accept other employment during the Employment Period.  In the event you commence employment with another company during the Employment Period, the terms and conditions of this agreement shall be subject to review and may be revised and prorated by the Compensation Committee of the Board of Directors.  
		

		
			﻿
		

			
	
			
				 IV.
			

			
	
			
			Compensation and Benefits.  

		
			﻿
		

			
	
			
				 a.
			

			
	
			
			Base Salary.  For the Employment Period, you will continue to receive compensation at an annualized rate of $461,250 to be paid bi-weekly. 

		
			﻿
		

			
	
			
				 b.
			

			
	
			
			Cash Incentive Payment for 2019.   For the calendar year 2019 only, you will be eligible to receive a  cash incentive payment of $150,000, the amount of your full-year target bonus opportunity for Individual Objectives in 2019.  This cash incentive payment is contingent upon your successful completion of the transition items listed in Section III. of this letter agreement, as determined by the Company’s Chief Executive Officer in his sole discretion.  Any cash incentive payment approved by the Chief Executive Officer shall be paid on December 31, 2019. 

		
			﻿
		

			
	
			
				 c.
			

			
	
			
			Long-term Incentive Compensation.  For the calendar year 2019, you will continue to be eligible to receive $100,000 in long-term cash incentive compensation (LTCI) upon vesting on December 31, 2019,  provided you remain in the continuous employment of the Company and its subsidiaries up to and through the vesting date.   This represents 50% of your 2019 LTCI grant.  The remainder of your 2019 LTCI grant shall be forfeited.

		
			﻿
		

			
	
			
				 d.
			

			
	
			
			Standard Benefits.   During the Employment Period, you will be entitled, at your election, to participate in all employee benefit plans and programs generally available to other Company executives, including without limitation, medical, dental, life, and short and long-term disability insurance.  Your participation in any benefit plan or program will be subject to the terms, conditions, eligibility and premium payment requirements of the applicable plans. 

		
			﻿
		

		
			Additionally, at the end of your Employment Period, you will be entitled to an additional payment of approximately $13,572, which is equal to six times the monthly COBRA premium applicable to your current coverage level under the A. H. Belo Health and Welfare Benefit Plan. This payment will be paid on your last paycheck in 
		

		 

		

			2

		

 

		January 2020 and may vary due to increases in 2020 COBRA premiums. 
		

		
			﻿
		

			
	
			
				 e.
			

			
	
			
			Expenses.   During the Employment Period, if you are asked to incur expenses on behalf of the Company you will be entitled to receive reimbursement from the Company for customary, limited travel and business expenses you occur in connection with your employment and as approved by the Chief Executive Officer of the Company.  You must account for and document those expenses in accordance with the policies and procedures established by the Company. 

		
			﻿
		

			
	
			
				 f.
			

			
	
			
			Paid Time Off Balance.  Any 2019 PTO days remaining unused as of the Effective Date will be paid on the next payroll after the Effective Date.   You agree to waive accrual of additional PTO during the remainder of the Employment Period.

		
			﻿
		

			
	
			
				 V.
			

			
	
			
			General Release.    You agree that, as a condition to receiving any benefits or payments under this letter agreement, and in consideration of the Employment Period and other payments and compensation described in this Agreement, together with a waiver by the Company of Section 8(a) [Non-Competition] of the Employment Agreement and the amendment to Section 8(b) as set forth below,  you will be required to execute and deliver a  non-revocable general release, in the form attached hereto, of all claims (except as otherwise expressly set forth in such general release) arising out of your service as an employee of the Company, its subsidiaries or any of their affiliates and the termination of such relationship,  in the form previously approved by both you and the Company. Section 8(a) [Non-Competition] of the Employment Agreement shall be of no further force or effect from and after the Effective Date. Effective as of the Effective Date, Section 8(b)[Customer Non-Solicitation] of the Employment Agreement shall be amended to add the following sentence at the end of the paragraph:  "The terms "customer" and "client" as used in this Section 8(b) shall not include (i) customers and clients of the Company or The Dallas Morning News who have not done business with Belo + Company; or (ii) those inactive customers or clients who have not done business with Belo + Company for a period of twelve  (12) months prior to the effective date of this letter agreement. The terms “Non-Competition Term,” “Business,” and “Territory” shall continue to have the meanings set forth in Section 8(a).

		
			
		

		
			 
		

		

		

		 

		

			3

		

 

		

			 

		

		All other post-employment covenants of your Employment Agreement will remain in full force and effect, including but not limited to Section 7 [Non-Disclosure], Section  8(b) [Customer Non-Solicitation](except as amended by this letter agreement),  Section 8(c) [Employee Non-Solicitation],  Section 9 [Non-Disparagement], Section 10 [Return of Documents and Property] and Section 13 [Acknowledgement of Company’s Right in Work Product and Assignment].
		

		
			VI.       Lastly, following the Employment Period, you agree to provide reasonable assistance and cooperation in any ongoing matters in which you were involved or are knowledgeable, including any litigation or governmental agency proceedings.
		

		
			﻿
		

		
			Tim, we value your commitment to a successful transition. Our goal is to ensure a smooth transition for you and your family while advancing the best interests of Belo + Company and A. H. Belo Corporation.  
		

		
			﻿
		

		
			By signing below, I, Tim Storer, have reviewed the foregoing terms and conditions from A. H. Belo Corporation as they relate to my employment with the Company.  I have had the opportunity to review all areas and clarify all areas of confusion or disagreement. By signing below, I agree to the terms and conditions in this document. 
		

		
			﻿
		

			
					
						﻿

					
					
						 

					
					
						 

					
					
						 

				
	
					
						﻿

				
	
					
						/s/ Tim Storer

					
					
						 

					
					
						7/26/2019

				
	
					
						 Tim Storer

					
					
						 

					
					
						Date

				
	
					
						 President

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 /s/ Robert W. Decherd

					
					
						 

					
					
						7/29/2019

				
	
					
						 Robert Decherd

					
					
						 

					
					
						Date

				
	
					
						 Chief Executive Officer

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						/s/ Julie Hoagland

					
					
						 

					
					
						7/29/2019

				
	
					
						Julie Hoagland

					
					
						 

					
					
						Date

				
	
					
						SVP, Chief People Officer

					
					
						 

					
					
						 

				

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		

		

		 

		

			4

		

 

		
		

		
			[FORM OF] GENERAL RELEASE

		

		
			This General Release ("Agreement"), entered into by and between Timothy M. Storer ("you" or the "Employee") and A. H. Belo Corporation (the "Company") as of the Effective Date, arises from your departure from the Company.
		

		
			﻿
		

		
			This Agreement is legally-binding.  You are hereby advised to consult with an attorney before signing it.
		

		
			﻿
		

		
			You acknowledge that your last day of employment with the Company is December 31, 2019 (the "Termination Date").  The Company has offered you the payments described in the Letter Agreement effective as of July 17, 2019 (the “Letter Agreement”), on the terms and conditions set forth in the Letter Agreement, in conjunction with your departure from the Company.  You agree that you are not entitled to any such payments on or after the Termination Date, unless you execute this Agreement by signing the signature line at the conclusion of this Agreement, and do not revoke it during the revocation period described below.
		

		
			﻿
		

			
	
			
				 1.
			

			
	
			
			Letter Agreement Payments.  You shall receive such payments, subject to the terms and conditions of the Letter Agreement and to applicable taxes and related withholdings.  In the event that you revoke this Agreement, you will be ineligible for any such payments on or after December 31, 2019.  You acknowledge that such payments are in addition to any monies or benefits to which you are already entitled and that such payments represent good and sufficient consideration for the releases set forth in this Agreement.  

		
			﻿
		

			
	
			
				 2.
			

			
	
			
			General Release.  In consideration for such payments described in the Letter Agreement, to which you are otherwise not entitled, you agree to waive and release the Company, its affiliates and subsidiaries, and all of their current and former respective officers, directors, employees, stockholders, representatives and agents, including their successors and assigns (collectively the "Releasees"), with respect to any and all claims, losses, liabilities, obligations and causes of action, known and unknown, arising out of, connected with, or relating to: (i) your employment; (ii) the Releasees' refusal or failure to continue your employment; or (iii) your departure from the Company, including, but not limited to, claims for compensation, commissions, bonuses, stock options, other wages and benefits, breach of contract, wrongful termination, impairment of economic opportunity, intentional infliction of emotional distress, claims based on personal injury, work-related accident, any breach of implied or express covenant of good faith and fair dealing, violation of public policy, or any other contract, tort or personal injury claim, or claim based on any municipal, state or federal statute, regulation or ordinance relating to employment, employment discrimination or retaliation, including but not limited to Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000 et seq.; The Civil Rights Act of 1866, as amended, 42 U.S.C. § 1981; The Civil Rights Act of 1991, as amended, 42 U.S.C. § 1981a; The Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. § 621 et 
		

		 

		

			 

		

 

			seq.; Americans With Disabilities Act, as amended, 42 U.S.C. § 12101 et seq.; Fair Labor Standards Act, as amended, 29 U.S.C. § 201, et seq.; Equal Pay Act, as amended, 29 U.S.C. § 201 et seq.; National Labor Relations Act, as amended, 29 U.S.C. § 151 et seq.; Worker Adjustment and Retraining Notification Act, as amended, 29 U.S.C. § 2101 et seq., Employee Retirement Income Security Act, as amended, 29 U.S.C. § 1000 et seq.; Family and Medical Leave Act, as amended, 29 U.S.C. § 2601, et seq.; Chapter 21 of the Texas Labor Code or any other statute, rule, regulation, ordinance, or common civil or other law, or judicial or administrative interpretation whether promulgated by Federal, State, local or other jurisdiction or political subdivision. 

		
			﻿
		

		
			Notwithstanding any provision of this Agreement to the contrary (including but not limited to this Section 2 and Section 3 below), and for the sake of clarity, you are not releasing or waiving, with respect to your service as an officer, director, manager, employee or agent of, or in any other similar role for, the Company and its affiliates on or prior to the Termination Date (a) the obligations of the Company and its affiliates to indemnify, defend and hold you harmless against third party claims (which shall include derivative shareholder claims) under the Company’s and its affiliates’ respective organizational documents, the Texas Business Organizations Code, or the Delaware General Corporation law, as applicable law, or (b) your rights and eligibility for coverage or the obligations of any insurer under any insurance policies maintained by or for the benefit of the Company or its affiliates.
		

		
			﻿
		

		
			
		

		
			﻿
		

			
	
			
				 3.
			

			
	
			
			Waiver of Claims.  By signing this Agreement, you—on behalf of yourself, your family, assigns, representatives, agents, estate, heirs, beneficiaries, executors, administrators, successors, and/or attorneys, if any— agree to give up any right or entitlement you may have under Federal, State or local law against the Releasees, including but not limited to The Age Discrimination in Employment Act of 1967, as amended, concerning any events related to your employment or your departure from the Company, or the Company’s failure to continue your employment.  This Agreement extinguishes any potential monetary recovery from employment discrimination claims you may have relating to your employment with the Company and your departure from the Company existing on the date you sign this Agreement.

		
			﻿
		

		
			You represent and warrant that you have not assigned to any third party any claim involving the Releasees or authorized any third party to assert on your behalf any claim against the Releasees.  If a third party asserts a claim against the Releasees on your behalf or includes you as a class member in any class action involving any claim released under this Agreement, you shall not accept any benefits or damages relating or arising out of such claim.
		

		
			﻿
		

		

		

		 

		

			 

		

 

		Nothing in this Agreement will prevent you from initiating or participating in any State or Federal agency administrative proceeding including proceedings before the Equal Employment Opportunity Commission or from testifying at an administrative hearing, deposition, or in court in response to a lawful subpoena.
		

		
			﻿
		

			
	
			
				 4.
			

			
	
			
			No Admission of Wrongdoing.  This Agreement shall not in any way be construed as an admission of liability or as an admission that any of the Releasees have acted wrongfully with respect to you.  Each of the Releasees specifically denies and disclaims any such liability or wrongful acts.

		
			﻿
		

			
	
			
				 5.
			

			
	
			
			Venue and Applicable Law.  This Agreement shall be performed in Dallas, Texas, and the laws of the State of Texas shall govern the enforceability, interpretation and legal effect of this Agreement.  The parties shall submit to the jurisdiction of the Federal and State courts sitting in Dallas, Texas, for all purposes relating to the validity, interpretation or enforcement of this Agreement, including, without limitation, any application for injunctive relief.

		
			﻿
		

			
	
			
				 6.
			

			
	
			
			Remedies.  Any material breach by you of the terms and conditions contained in this Agreement shall give Company the right to discontinue the performance of any unperformed duties and obligations under this Agreement to the extent permitted by applicable law, and shall entitle the Company to legal, injunctive, or other equitable relief on account of such breach.

		
			﻿
		

			
	
			
				 7.
			

			
	
			
			Entire Agreement.  This Agreement, the Letter Agreement and your Amended and Restated Employment Agreement dated December 10, 2018 (as amended by the Letter Agreement) constitute our entire agreement and supersede any prior or contemporaneous agreements or understandings between the Company and you, except for any confidentiality obligations referred to elsewhere herein.  You acknowledge that you enter into this Agreement without reliance on any written or oral promise or representation, other than those contained in this Agreement and the Letter Agreement.

		
			﻿
		

			
	
			
				 8.
			

			
	
			
			Severability.  If any provision of this Agreement shall be determined by a court to be void or unenforceable, the remaining provisions shall remain effective and legally binding, and the void or unenforceable term shall be deemed not to be a part of this Agreement.

		
			﻿
		

			
	
			
				 9.
			

			
	
			
			Headings.  The headings in each paragraph herein are for convenience of reference only and shall be of no legal effect in the interpretation of the terms hereof.

		
			﻿
		

			
	
			
				 10.
			

			
	
			
			Waiver.  If you breach any term of the Agreement, any delay by the Company to enforce the Agreement shall not be deemed a waiver or acceptance.  No waiver shall bind the Company unless supported by consideration, executed in writing, and delivered to you by an authorized Company officer.

		
			﻿
		

		 

		

			 

		

 

			
	
			
				 11.
			

			
	
			
			Attorneys' Fees.  In any dispute between the Company and you regarding the terms of this Agreement and/or any alleged breach thereof, the prevailing party shall be entitled to recover its costs and reasonable attorneys' fees arising out of such dispute, provided that such recovery is not otherwise prohibited by law.

		
			﻿
		

			
	
			
				 12.
			

			
	
			
			Knowing and Voluntary Agreement.    You are advised in writing to consult with an attorney before executing this Agreement.  You acknowledge and agree that:  (i) after you received a copy of this Agreement in writing you had adequate opportunity to review this Agreement; (ii) you fully understand its contents; (iii) you have been advised to consult an attorney before signing it; and (iv) you enter into this Agreement knowingly, voluntarily and after any consultations with your attorney or other advisor, as you deem appropriate.

		
			﻿
		

			
	
			
				 13.
			

			
	
			
			Review Period, Execution and Revocation.    You acknowledge that you had at least 45 calendar days from your receipt of this Agreement, on (Date) to consider whether to accept its terms.  After signing the Agreement, and returning it to Sandi Scott, Director/Human Resources, The Dallas Morning News, 1954 Commerce St., Dallas, Texas 75201, by (Date), you will have seven (7) calendar days to consider whether to revoke it.  The Agreement will not be effective until the expiration of seven (7) calendar days after you sign the Agreement without revoking it.  You acknowledge that this Agreement will become effective, fully enforceable and irrevocable following the expiration of seven (7) days after your signing of this Agreement ("Effective Date").

		
			﻿
		

		
			If you choose to revoke this Agreement, you must notify Sandi Scott, in writing, before 5:00 p.m. on the day immediately preceding the Effective Date.
		

		
			﻿
		

		
			IN WITNESS WHEREOF, this General Release has been executed by each of the listed parties below. 
		

		
			﻿
		

		
			﻿
		

			
					
						﻿

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Timothy M. Storer

					
					
						A. H. Belo Corporation

				
	
					
						﻿

				
	
					
						﻿

					
					
						 

				
	
					
						Signature:

					
					
						 

					
					
						By:

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

					
					
						[Name/Title of Officer]

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 Date:

					
					
						 

					
					
						 Date:

					
					
						 

					
					
						 

				

		
			﻿
		

		
			﻿
		

		
			﻿

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]